Format

Send to

Choose Destination
Haematologica. 2018 Feb;103(2):e46-e49. doi: 10.3324/haematol.2017.181511. Epub 2017 Nov 2.

Short-term administration of JAK2 inhibitors reduces splenomegaly in mouse models of β-thalassemia intermedia and major.

Author information

1
Department of Pediatrics, Division of Hematology, Children's Hospital of Philadelphia (CHOP), PA, USA.
2
Penteli's Children's Hospital, Pediatric Department, Athens, Greece.
3
Adaptimmune Therapeutics Ltd., Abingdon, UK.
4
Novartis Pharma AG, Basel, Switzerland.
5
Department of Pediatrics, Division of Hematology, Children's Hospital of Philadelphia (CHOP), PA, USA rivellas@email.chop.edu.
PMID:
29097498
PMCID:
PMC5792284
DOI:
10.3324/haematol.2017.181511
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center